Mistri, Damiano http://orcid.org/0000-0003-0765-1255
Cacciaguerra, Laura http://orcid.org/0000-0001-9342-2410
Storelli, Loredana
Meani, Alessandro http://orcid.org/0000-0001-8189-0452
Cordani, Claudio http://orcid.org/0000-0002-9014-7887
Rocca, Maria A. http://orcid.org/0000-0003-2358-4320
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Article History
Received: 3 November 2021
Revised: 24 January 2022
Accepted: 18 February 2022
First Online: 12 March 2022
Declarations
:
: D. Mistri has no relevant financial or non-financial interest to disclose; L. Cacciaguerra received speaker and consultant honoraria from ACCMED, Roche, BMS Celgene, and Sanofi; L. Storelli has no relevant financial or non-financial interest to disclose; A. Meani received speaker honoraria from Biogen Idec; C. Cordani has no relevant financial or non-financial interest to disclose; M.A. Rocca received speaker honoraria from Bayer, Biogen, Bristol Myers Squibb, Celgene, Genzyme, Merck Serono, Novartis, Roche, and Teva, and receives research support from the MS Society of Canada and Fondazione Italiana Sclerosi Multipla; M. Filippi is Editor-in-Chief of the <i>Journal of Neurology</i>, Associate Editor of <i>Human Brain Mapping</i>, Associate Editor of <i>Radiology</i>, and Associate Editor of <i>Neurological Sciences</i>, received compensation for consulting services and/or speaking activities from Alexion, Almirall, Bayer, Biogen, Celgene, Eli Lilly, Genzyme, Merck-Serono, Novartis, Roche, Sanofi, Takeda, and Teva Pharmaceutical Industries, and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).
: The local ethical standards committee on human experimentation approved this study.
: Informed consent was obtained from all individual participants included in the study.